Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Boehringer Ingelheim
National Cancer Institute (NCI)
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Eli Lilly and Company
Pfizer
PMV Pharmaceuticals, Inc
Mayo Clinic
Eli Lilly and Company
Genmab
Pfizer
Hoffmann-La Roche
Canadian Cancer Trials Group
Roswell Park Cancer Institute
Merck Sharp & Dohme LLC
Arcus Biosciences, Inc.
Revolution Medicines, Inc.
Verastem, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Amgen
Pfizer
Merck Sharp & Dohme LLC